75 related articles for article (PubMed ID: 741407)
21. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report.
Lane PR; Moreland AA; Hogan DJ
Arch Dermatol; 1990 Sep; 126(9):1211-3. PubMed ID: 2396838
[TBL] [Abstract][Full Text] [Related]
22. [Systemic effects of topical corticosteroid therapy (author's transl)].
Kobori T; Toda K; Saito T; Aoki K; Kukuta A
Nihon Hifuka Gakkai Zasshi; 1976 Oct; 86(12):825-31. PubMed ID: 1034098
[No Abstract] [Full Text] [Related]
23. The use and abuse of 0.05 per cent clobetasol propionate in dermatology.
Harris DW; Hunter JA
Dermatol Clin; 1988 Oct; 6(4):643-7. PubMed ID: 3229014
[TBL] [Abstract][Full Text] [Related]
24. Lupus pernio: successful treatment with a potent topical corticosteroid.
Khatri KA; Chotzen VA; Burrall BA
Arch Dermatol; 1995 May; 131(5):617-8. PubMed ID: 7741556
[No Abstract] [Full Text] [Related]
25. One more topical corticosteroid.
Med Lett Drugs Ther; 1978 Dec; 20(25):112. PubMed ID: 732752
[No Abstract] [Full Text] [Related]
26. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
27. Penile verrucous carcinoma.
Yeager JK; Findlay RF; McAleer IM
Arch Dermatol; 1990 Sep; 126(9):1208-10. PubMed ID: 2396837
[TBL] [Abstract][Full Text] [Related]
28. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
29. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
Fleischer AB; Feldman SR
Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568
[TBL] [Abstract][Full Text] [Related]
30. Topical corticosteroids.
Möller H
Int J Dermatol; 1989 May; 28(4):279. PubMed ID: 2722349
[No Abstract] [Full Text] [Related]
31. A clinical trial of clobetasol propionate in Filipino vitiligo patients.
Geraldez CB; Gutierrez GT
Clin Ther; 1987; 9(5):474-82. PubMed ID: 3311364
[TBL] [Abstract][Full Text] [Related]
32. Response of plasma cell orificial mucositis to topically applied steroids.
Jones SK; Kennedy CT
Arch Dermatol; 1988 Dec; 124(12):1871-2. PubMed ID: 3190265
[No Abstract] [Full Text] [Related]
33. The use of Dermovate in the treatment of psoriasis.
Carruthers JA
Can Med Assoc J; 1978 Sep; 119(6):563-4. PubMed ID: 709447
[No Abstract] [Full Text] [Related]
34. The use of a corticosteroid cream for immediate reduction in the clinical signs of acne vulgaris.
Hull SM; Cunliffe WJ
Acta Derm Venereol; 1989; 69(5):452-3. PubMed ID: 2572120
[TBL] [Abstract][Full Text] [Related]
35. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
Meyer E; Smith EW; Haigh JM; Kanfer I
Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
[TBL] [Abstract][Full Text] [Related]
36. Clobetasol-induced milia.
Iacobelli D; Hashimoto K; Kato I; Ito M; Suzuki Y
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):215-7. PubMed ID: 2768571
[TBL] [Abstract][Full Text] [Related]
37. [Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Blum G; Kröpfli P; Küng D; Suter H
Ther Umsch; 1984 Jun; 41(6):420-4. PubMed ID: 6379974
[No Abstract] [Full Text] [Related]
38. Managing chronic skin conditions with two differing topical corticosteroids.
Woodbridge PA; Sparkes CG
Dermatologica; 1979; 158(4):299-306. PubMed ID: 428616
[TBL] [Abstract][Full Text] [Related]
39. [Pemphigoid gestationis: treatment by topical class I corticosteroid].
Valeyrie L; Lebrun-Vignes B; Bodak N; Grossin M; Descamps V; Crickx B; Bélaïch S
Ann Dermatol Venereol; 2001 May; 128(5):638-40. PubMed ID: 11427799
[TBL] [Abstract][Full Text] [Related]
40. Topical use of betamethasone-17-benzoate in common dermatological disorders.
Goswami N; Ghosh KK; Panja RK
Indian J Dermatol; 1974 Jan; 19(2):46-52. PubMed ID: 4607695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
